Phil Morton, Ph.D., Chief Technology Officer 

Oct. 11 | 9:15am | Ecolab Life Sciences Ballroom 

Nottingham, UK 


Albumedix, now part of Sartorius, is a science-driven company and recognized leader in best-in-class albumin-enabled solutions. Established in the UK in 1984, with a mission to empower excellence, Albumedix has supported its life-science partners to deliver hundreds of millions of safe, clinical and marketed therapeutic doses globally. Albumedix’ solutions include the world’s only USP-NF compliant recombinant human albumin (Recombumin®), client-centric development and compliance services and drug-enhancing technologies (Veltis®). By continually striving for more and collaboratively challenging the status quo, Albumedix enables the development and commercialization of advanced therapies and next-generation biopharmaceuticals to benefit people worldwide. 

By using this website you agree to accept our Privacy Policy and Terms & Conditions